17 Followers on Owler

OBT

is a biotechnology company that focuses on the discovery and development of therapeutics for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

OBT

is a biotechnology company that focuses on the discovery and development of therapeutics for the treatment of cancer... Read more
OBT Founder & CEO: Christian Rohlff

Founder & CEO

Christian Rohlff

CEO Approval Rating

88/100

2003

PrivateIndependent Company

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$22.6M

News

Partnership
Mar 20, 2025
Pharmabiz
Oxford BioTherapeutics inks multiyear collaboration with Roche to discover novel targets for antibodybased therapeutics to treat cancer
Conference Presentation
Oct 31, 2024
GlobalNewswire
Oxford BioTherapeutics to Present at World ADC Conference 2024

OBT Competitors

1CytomX
2ADC Therapeutics
3ADC Bio
4Paragon Gene
5Apexigen
6Cytovance
7BioAtla
8ImmunGene
9Meditope
10ImmunoGen
Unlock 13 + competitors

Trending Companies